WaveMan · Form 4
Biotechnology Value Fund II LP insider trades
> Search tickers & screens ⌘K
LIVE

Biotechnology Value Fund II LP insider trades

Biotechnology Value Fund II LP has filed 12 Form 4s with the SEC that we hold, for Kymera Therapeutics, Inc. (KYMR) (Director), RPTX (10% owner), ALLK (10% owner) and Eledon Pharmaceuticals, Inc. (ELDN) (10% owner), among 8 companies in all. Across all of them we count 20 purchases worth $32.7M and 4 sales worth $173.7M reported on Form 4. In the last 12 months: 0 purchases ($0) and 4 sales ($173.7M). The largest single trade was a sale of 837,914 shares of Kymera Therapeutics, Inc. worth $89.2M, dated 2026-06-26. The first filing on our record is dated 2022-01-21 and the latest 2026-06-26.

Kymera Therapeutics, Inc. (KYMR)

Director · 4 filings · 11 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-08-22P, purchase reported on Form 4285,046$7.4M2022-08-23
2022-08-22P, purchase reported on Form 427,117$705.0K2022-08-23
2022-08-22P, purchase reported on Form 4233,362$6.1M2022-08-23
2023-01-11P, purchase reported on Form 410,961$327.6K2023-01-13
2023-01-11P, purchase reported on Form 411,149$333.2K2023-01-13
2023-01-12P, purchase reported on Form 415,912$497.1K2023-01-13
2023-01-12P, purchase reported on Form 42,985$93.3K2023-01-13
2026-06-26S, sale reported on Form 4837,914$89.2M2026-06-26
2026-06-26S, sale reported on Form 451,858$5.5M2026-06-26
2026-06-26S, sale reported on Form 4113,289$12.1M2026-06-26
2026-06-26S, sale reported on Form 4627,597$66.8M2026-06-26

RPTX

10% owner · 2 filings · 6 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-01-19P, purchase reported on Form 4577,798$8.1M2022-01-21
2022-01-19P, purchase reported on Form 4412,264$5.8M2022-01-21
2022-01-19P, purchase reported on Form 47,899$111.4K2022-01-21
2022-06-13P, purchase reported on Form 46,168$78.5K2022-06-15
2022-06-13P, purchase reported on Form 474,666$950.5K2022-06-15
2022-06-13P, purchase reported on Form 468,327$869.8K2022-06-15

ALLK

10% owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Eledon Pharmaceuticals, Inc. (ELDN)

10% owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

MoonLake Immunotherapeutics (MLTX)

Director, 10% owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

RAIN (RAIN)

Director · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

THRD

10% owner · 1 filing · 3 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-12-20P, purchase reported on Form 49,597$39.4K2022-12-22
2022-12-20P, purchase reported on Form 487,831$361.0K2022-12-22
2022-12-20P, purchase reported on Form 4116,635$479.4K2022-12-22

XOMA Royalty Corp (XOMA)

Director, 10% owner · 1 filing · 4 purchases and sales
Trade dateCodeSharesValue as filedFiled
2023-01-05P, purchase reported on Form 415,670$288.2K2023-01-09
2023-01-05P, purchase reported on Form 43,330$61.2K2023-01-09
2023-01-06P, purchase reported on Form 41,573$34.6K2023-01-09
2023-01-06P, purchase reported on Form 41,676$36.8K2023-01-09
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1102444) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms